Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Blueberries Medical Corp C.BBM

Alternate Symbol(s):  BBRRF

Blueberries Medical Corp. is a Canada-based company, which is a licensed producer of psychoactive and non-psychoactive cannabis by-products in Colombia. The Company is engaged in the growth, cultivation, and development of medicinal cannabis and related products with operations in Colombia. Its operations are mainly focused on the Bogota Savannah, in central Colombia. The Company is focused on processing and supplying medicinal-grade Cannabis oil extracts, medical flowers, and related products. It is developing and commercializing a range of cannabis-derived ingredients, including high and low tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoids. The Company’s subsidiaries include Blueberries Research Corporation (BRC) and Blueberries SAS (BBSAS). Blueberries SAS is a licensed producer and distributor of medicinal Cannabis and Cannabis-derived products in Colombia.


CSE:BBM - Post by User

Comment by Golddetectoron Nov 18, 2020 11:08pm
132 Views
Post# 31928546

RE:Well

RE:Well End of the month will have the q3 and sales projections update. Nothing much is expected for q3. I'm just interested in sales status. They are cutting cost according to the tweets and email reply. Do not expect much in q4. Significant revenues expected next year. Accumulation going on at 5 cents.
<< Previous
Bullboard Posts
Next >>